Growth hormone for hard-to-treat stomach paralysis
Treatments studied
Part of Digestive system clinical trials.
This study tests if growth hormone can help people with long-term stomach paralysis (gastroparesis) that hasn't improved with standard care. It looks at whether the treatment reduces symptoms like nausea and feeling full too quickly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had stomach paralysis symptoms for more than 6 months that did not get better with standard treatments.
- Your symptom score (GCSI) is greater than 21.
- You do not have diabetes.
- You have not used growth hormone therapy before.
- You are not pregnant or nursing, and you are not on oral estrogen therapy (if you are a woman).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether abnormal function of the pyloric “stomach outlet” muscle is linked to gastroparesis symptoms (slow stomach emptying). It may help researchers better understand what causes symptoms and guide future treatments.
This study follows people with drug-refractory gastroparesis (stomach paralysis symptoms that don’t improve with usual medicines) to better understand how symptoms and nutrition change over time. Your information may help researchers understand patterns that could improve care.
This study looks at how a gastric electrical stimulator works to treat gastroparesis. It compares people who feel their symptoms improve a lot or not much, to understand the device's effects.
This study tests if growth hormone can safely help children who are shorter than average for their age and gender. It is for children with certain conditions that cause short stature.
This study tests if giving a human growth hormone can help older adults recover from a serious brain injury. It is for patients who have low protein levels in their blood, which may slow down healing.
This study tests different doses of a long-acting growth hormone (PEG-rhGH) to find the best amount for helping children with short stature grow more. It includes kids who are not yet in puberty or who are in the early to middle stages of puberty.
Hear when a new Gastroparesis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.